Biosig Technologies Inc
NASDAQ:BSGM
Biosig Technologies Inc
Net Income (Common)
Biosig Technologies Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biosig Technologies Inc
NASDAQ:BSGM
|
Net Income (Common)
-$29.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Biosig Technologies Inc's Net Income (Common)?
Net Income (Common)
-29.1m
USD
Based on the financial report for Dec 31, 2023, Biosig Technologies Inc's Net Income (Common) amounts to -29.1m USD.
What is Biosig Technologies Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-11%
Over the last year, the Net Income (Common) growth was -7%. The average annual Net Income (Common) growth rates for Biosig Technologies Inc have been 18% over the past three years , -10% over the past five years , and -11% over the past ten years .